ELAINE STROHL: Open Payments
NPI 1265533616 · BRYN MAWR, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,157 in 52 payments from 13 companies in 2025. Trend: 2023 $1,658 · 2024 $1,376 · 2025 $1,157
Food & beverage: $1,157
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $258 |
| PFIZER INC. | 9 | $155 |
| Alexion Pharmaceuticals, Inc. | 1 | $125 |
| SCPHARMACEUTICALS INC. | 4 | $123 |
| Novartis Pharmaceuticals Corporation | 6 | $121 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $101 |
| E.R. Squibb & Sons, L.L.C. | 4 | $85 |
| Boston Scientific Corporation | 2 | $52 |
| Abbott Laboratories | 2 | $43 |
| HEARTFLOW, INC. | 1 | $29 |
Products named: WAINUA, ELIQUIS, FUROSCIX, LEQVIO, FARXIGA, JARDIANCE, CAMZYOS, VYNDAQEL.
Industry payments across PA — which companies pay providers there.
